sharetrader
Page 3 of 2124 FirstFirst 123456713531035031003 ... LastLast
Results 21 to 30 of 21234
  1. #21
    Member
    Join Date
    May 2003
    Location
    Wellington, , New Zealand.
    Posts
    103

    Default

    This company seems to have little drive to commercialise its research. Its just a big tit for some Dunedin scientists to maintain their lifestyle. I wont hold my breath regarding the projected revenues in a year's time

  2. #22
    Member Scuffer's Avatar
    Join Date
    May 2007
    Location
    , , .
    Posts
    332

    Default

    You maybe right but they are not the only ones look around they are a few, funnily enough they are quite a few around Dunedin.
    I don't bloody believe it

  3. #23
    Member
    Join Date
    Apr 2004
    Location
    , , .
    Posts
    263

    Default

    I notice that in the recent capital raising Peter Masfen raised his shareholding to 12% and the ACC have purchased a 5% stake.The ACC stake is small bananas in the grand scheme of things but interesting given the state of the listed biotechs at the moment.

  4. #24
    Senior Member
    Join Date
    May 2000
    Location
    New Zealand.
    Posts
    1,221

    Default

    I was surprised to see ACC popping up at this point in time...
    Death will be reality, Life is just an illusion.

  5. #25
    Share Collector
    Join Date
    Mar 2005
    Location
    Porirua
    Posts
    3,509

    Default

    Quote Originally Posted by Steve View Post
    I was surprised to see ACC popping up at this point in time...
    ACC seem to own virtually everything on the NZX...

    ....anyway, could be an okay time to own PEB if they were to actually meet their timeframes for completion of the bladder cancer assay clinical trial in the next 6 months (with first revenues expected "soon" after). Full year report due soon and will see how they are progressing.

    Web-site is a disappointment with no 2007 report or interim report available there - given they are supposed to be going to the "electronically available" option, this seems a little remiss.

  6. #26
    Share Collector
    Join Date
    Mar 2005
    Location
    Porirua
    Posts
    3,509

    Default

    ...something I posted on another forum a few months ago in regard to the fariness of the $12m market cap relative to market prospects...

    Actually, also of interest in this regard is the progress of Matritech who were the major US producer of the Bladderchek test. Matritech was expecting FY07 revenues of around $US15m, coming largely from this business. However, the company continued to report quarterly losses and the assets were recently sold to Inverness Medical Innovations for $US36m. Matritech has since filed for dissolution. The sale and dissolution was expected to realise $US10 - $US12m for shareholders.

  7. #27
    Senior Member
    Join Date
    May 2000
    Location
    New Zealand.
    Posts
    1,221

    Default

    How does the PEB product differ from what Matritech did?
    Death will be reality, Life is just an illusion.

  8. #28
    Share Collector
    Join Date
    Mar 2005
    Location
    Porirua
    Posts
    3,509

    Default

    My understanding is that the PEB product contains a prognostic as well as diagnostic aspect. But I am not entirely sure. I'm also guessing it is a more expensive test. Not an expert in these things.

    Of course PEB also have the colo-rectal and gastric tests in pipeline plus early stage products and IP.

  9. #29
    Senior Member
    Join Date
    May 2000
    Location
    New Zealand.
    Posts
    1,221

    Default

    Thanks for the points of difference...
    Death will be reality, Life is just an illusion.

  10. #30
    Share Collector
    Join Date
    Mar 2005
    Location
    Porirua
    Posts
    3,509

    Default

    I have finally been able to lay my eyes on the annual report, via the companies office web-site where it has now been lodged.

    Last year, I recall seeing the notice advising that they would now be not issuing paper copies of the report except where requested and the report would be available on-line. That seemed fine until I received the "shareholder password" in the mail - a few weeks before the report was due to be put on line. Of course, it went into my totally safe filing system - and was never found again.

    Anyway, I am still puzzled as to why a listed company would password protect its annual report on its web-site - I thought listed companies were required to provide potential investors with a copy of their annual report on request anyway? Even if that is not the case, the report is now available (one month later) on the companies web-site, so why the secrecy?

Tags for this Thread

Bookmarks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •